matrigel ® (gfr) basement membrane matrix Search Results


90
Becton Dickinson matrigel gfr basement membrane matrix, phenol red-free
Matrigel Gfr Basement Membrane Matrix, Phenol Red Free, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrigel gfr basement membrane matrix, phenol red-free/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
matrigel gfr basement membrane matrix, phenol red-free - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences matrigel® gfr high concentration (hc) basement membrane matrix
In vivo myogenic differentiation of control or miR10a, miR425 or miR5100 mimics transfected SC-derived myoblasts or MIPCs subcutaneously transplantated in <t>Matrigel®</t> and analyzed 21 days after transplantation. A Immunolocalization of skeletal muscle myosin in sections of Matrigel® containing differentiating cells; myosin—green, cell nuclei—blue; C Level of myogenesis associated transcripts in cells transplanted within Matrigel®. Three independent analyzes were performed, all reactions were performed in duplicates. Differences were considered statistically significant when p < 0.05 (marked with asterisks, * p < 0.05). Scale: 20 µm
Matrigel® Gfr High Concentration (Hc) Basement Membrane Matrix, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrigel® gfr high concentration (hc) basement membrane matrix/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
matrigel® gfr high concentration (hc) basement membrane matrix - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences gfr matrigel basement membrane matrix invasion chambers
Staufen1 knockdown inhibits Prostate Cancer cell invasion and motility. Motility and Invasion assays were performed following 48 h of Control (CTL) or Staufen1-shRNA (shStau1) expression. a Western blot analysis of Staufen1 expression showing a representative blot of Staufen1 with β-actin as a loading control in PC3 and DU145 cells. Each representative blot is cropped to show an n = 1 for each cell line from their respective full-length blot. Note that the DU145 cells used for Fig. 4 were also used for Fig. experiments and therefore a different representative image from the same blot was selected for each figure. Quantification of n = 4 is represented normalized to CTL. Data are Mean ± SD, One-Sample T-Test, **P < 0.01, ***P < 0.001. b Cells were seeded into transwell chambers containing membranes coated with or without <t>Matrigel</t> and incubated for 72 h and 24 h for PC3 and DU145 cells, respectively. Representative images of cells that passed through the transwell chamber at 40X magnification, scale bar = 20 μm, are displayed. Average number of cells/field of view is quantified for cell motility (no matrigel) and invasion (matrigel) as a percentage relative to CTL. Quantifications are for all data are n = 4. Data are Mean ± SD, Students T-Test, **P < 0.01, ***P < 0.001. Full length blots are presented in Supplemental Fig.
Gfr Matrigel Basement Membrane Matrix Invasion Chambers, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfr matrigel basement membrane matrix invasion chambers/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
gfr matrigel basement membrane matrix invasion chambers - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences gfr basement membrane matrigel matrix corning # 356231
Staufen1 knockdown inhibits Prostate Cancer cell invasion and motility. Motility and Invasion assays were performed following 48 h of Control (CTL) or Staufen1-shRNA (shStau1) expression. a Western blot analysis of Staufen1 expression showing a representative blot of Staufen1 with β-actin as a loading control in PC3 and DU145 cells. Each representative blot is cropped to show an n = 1 for each cell line from their respective full-length blot. Note that the DU145 cells used for Fig. 4 were also used for Fig. experiments and therefore a different representative image from the same blot was selected for each figure. Quantification of n = 4 is represented normalized to CTL. Data are Mean ± SD, One-Sample T-Test, **P < 0.01, ***P < 0.001. b Cells were seeded into transwell chambers containing membranes coated with or without <t>Matrigel</t> and incubated for 72 h and 24 h for PC3 and DU145 cells, respectively. Representative images of cells that passed through the transwell chamber at 40X magnification, scale bar = 20 μm, are displayed. Average number of cells/field of view is quantified for cell motility (no matrigel) and invasion (matrigel) as a percentage relative to CTL. Quantifications are for all data are n = 4. Data are Mean ± SD, Students T-Test, **P < 0.01, ***P < 0.001. Full length blots are presented in Supplemental Fig.
Gfr Basement Membrane Matrigel Matrix Corning # 356231, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfr basement membrane matrigel matrix corning # 356231/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
gfr basement membrane matrigel matrix corning # 356231 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences basal membrane extract corning matrigel® growth factor reduced (gfr) basement membrane matrix, phenol red-free, #356231
Staufen1 knockdown inhibits Prostate Cancer cell invasion and motility. Motility and Invasion assays were performed following 48 h of Control (CTL) or Staufen1-shRNA (shStau1) expression. a Western blot analysis of Staufen1 expression showing a representative blot of Staufen1 with β-actin as a loading control in PC3 and DU145 cells. Each representative blot is cropped to show an n = 1 for each cell line from their respective full-length blot. Note that the DU145 cells used for Fig. 4 were also used for Fig. experiments and therefore a different representative image from the same blot was selected for each figure. Quantification of n = 4 is represented normalized to CTL. Data are Mean ± SD, One-Sample T-Test, **P < 0.01, ***P < 0.001. b Cells were seeded into transwell chambers containing membranes coated with or without <t>Matrigel</t> and incubated for 72 h and 24 h for PC3 and DU145 cells, respectively. Representative images of cells that passed through the transwell chamber at 40X magnification, scale bar = 20 μm, are displayed. Average number of cells/field of view is quantified for cell motility (no matrigel) and invasion (matrigel) as a percentage relative to CTL. Quantifications are for all data are n = 4. Data are Mean ± SD, Students T-Test, **P < 0.01, ***P < 0.001. Full length blots are presented in Supplemental Fig.
Basal Membrane Extract Corning Matrigel® Growth Factor Reduced (Gfr) Basement Membrane Matrix, Phenol Red Free, #356231, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/basal membrane extract corning matrigel® growth factor reduced (gfr) basement membrane matrix, phenol red-free, #356231/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
basal membrane extract corning matrigel® growth factor reduced (gfr) basement membrane matrix, phenol red-free, #356231 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson matrigel basement membrane matrix gfr
Immunofluorescent staining for (a) CD31 (green) and (b) VE-Cadherin (red) in human iPS cell-derived endothelial cells. Nuclei were visualized with DAPI (blue). (c-g) Relative mRNA log 0 ratio in endothelial cells at differentiation day 9 (EC (D9)) and undifferentiated human iPS cell (iPSC) compared with human umbilical vein endothelial cell (HUVEC). CD31 (c), VE-Cadherin (d), eNOS (e), CD34 (f), and CD133 (g). (h) Tube formation assay. Human iPS cell-derived endothelial cells were recultured on <t>Matrigel</t> Basement Membrane Matrix <t>GFR</t> coated dish. (i) Immunofluorescent stained of CD31 for recultured cells on Matrigel. (j,k) Acetyl-LDL incorporation assay. Endothelial cells were incubated with acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL). Bright-field (j) and fluorescent (k) images. Scale bars: 50 μm in (a), (b) and (i), 100 μm in (h), 200 μm in (j) and (k).
Matrigel Basement Membrane Matrix Gfr, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrigel basement membrane matrix gfr/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
matrigel basement membrane matrix gfr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson gfr matrigel basement membrane matrix invasion chambers
Immunofluorescent staining for (a) CD31 (green) and (b) VE-Cadherin (red) in human iPS cell-derived endothelial cells. Nuclei were visualized with DAPI (blue). (c-g) Relative mRNA log 0 ratio in endothelial cells at differentiation day 9 (EC (D9)) and undifferentiated human iPS cell (iPSC) compared with human umbilical vein endothelial cell (HUVEC). CD31 (c), VE-Cadherin (d), eNOS (e), CD34 (f), and CD133 (g). (h) Tube formation assay. Human iPS cell-derived endothelial cells were recultured on <t>Matrigel</t> Basement Membrane Matrix <t>GFR</t> coated dish. (i) Immunofluorescent stained of CD31 for recultured cells on Matrigel. (j,k) Acetyl-LDL incorporation assay. Endothelial cells were incubated with acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL). Bright-field (j) and fluorescent (k) images. Scale bars: 50 μm in (a), (b) and (i), 100 μm in (h), 200 μm in (j) and (k).
Gfr Matrigel Basement Membrane Matrix Invasion Chambers, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfr matrigel basement membrane matrix invasion chambers/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
gfr matrigel basement membrane matrix invasion chambers - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson matrigel gfr basement membrane matrix ldev-free
Immunofluorescent staining for (a) CD31 (green) and (b) VE-Cadherin (red) in human iPS cell-derived endothelial cells. Nuclei were visualized with DAPI (blue). (c-g) Relative mRNA log 0 ratio in endothelial cells at differentiation day 9 (EC (D9)) and undifferentiated human iPS cell (iPSC) compared with human umbilical vein endothelial cell (HUVEC). CD31 (c), VE-Cadherin (d), eNOS (e), CD34 (f), and CD133 (g). (h) Tube formation assay. Human iPS cell-derived endothelial cells were recultured on <t>Matrigel</t> Basement Membrane Matrix <t>GFR</t> coated dish. (i) Immunofluorescent stained of CD31 for recultured cells on Matrigel. (j,k) Acetyl-LDL incorporation assay. Endothelial cells were incubated with acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL). Bright-field (j) and fluorescent (k) images. Scale bars: 50 μm in (a), (b) and (i), 100 μm in (h), 200 μm in (j) and (k).
Matrigel Gfr Basement Membrane Matrix Ldev Free, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrigel gfr basement membrane matrix ldev-free/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
matrigel gfr basement membrane matrix ldev-free - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


In vivo myogenic differentiation of control or miR10a, miR425 or miR5100 mimics transfected SC-derived myoblasts or MIPCs subcutaneously transplantated in Matrigel® and analyzed 21 days after transplantation. A Immunolocalization of skeletal muscle myosin in sections of Matrigel® containing differentiating cells; myosin—green, cell nuclei—blue; C Level of myogenesis associated transcripts in cells transplanted within Matrigel®. Three independent analyzes were performed, all reactions were performed in duplicates. Differences were considered statistically significant when p < 0.05 (marked with asterisks, * p < 0.05). Scale: 20 µm

Journal: Stem Cell Research & Therapy

Article Title: SDF-1 and NOTCH signaling in myogenic cell differentiation: the role of miRNA10a, 425, and 5100

doi: 10.1186/s13287-023-03429-x

Figure Lengend Snippet: In vivo myogenic differentiation of control or miR10a, miR425 or miR5100 mimics transfected SC-derived myoblasts or MIPCs subcutaneously transplantated in Matrigel® and analyzed 21 days after transplantation. A Immunolocalization of skeletal muscle myosin in sections of Matrigel® containing differentiating cells; myosin—green, cell nuclei—blue; C Level of myogenesis associated transcripts in cells transplanted within Matrigel®. Three independent analyzes were performed, all reactions were performed in duplicates. Differences were considered statistically significant when p < 0.05 (marked with asterisks, * p < 0.05). Scale: 20 µm

Article Snippet: 5 × 10 5 of control or transfected MIPCs or SC-derived myoblasts were suspended in 0.5 ml of Matrigel® GFR High Concentration (HC) basement membrane matrix (Corning).

Techniques: In Vivo, Control, Transfection, Derivative Assay, Transplantation Assay

Staufen1 knockdown inhibits Prostate Cancer cell invasion and motility. Motility and Invasion assays were performed following 48 h of Control (CTL) or Staufen1-shRNA (shStau1) expression. a Western blot analysis of Staufen1 expression showing a representative blot of Staufen1 with β-actin as a loading control in PC3 and DU145 cells. Each representative blot is cropped to show an n = 1 for each cell line from their respective full-length blot. Note that the DU145 cells used for Fig. 4 were also used for Fig. experiments and therefore a different representative image from the same blot was selected for each figure. Quantification of n = 4 is represented normalized to CTL. Data are Mean ± SD, One-Sample T-Test, **P < 0.01, ***P < 0.001. b Cells were seeded into transwell chambers containing membranes coated with or without Matrigel and incubated for 72 h and 24 h for PC3 and DU145 cells, respectively. Representative images of cells that passed through the transwell chamber at 40X magnification, scale bar = 20 μm, are displayed. Average number of cells/field of view is quantified for cell motility (no matrigel) and invasion (matrigel) as a percentage relative to CTL. Quantifications are for all data are n = 4. Data are Mean ± SD, Students T-Test, **P < 0.01, ***P < 0.001. Full length blots are presented in Supplemental Fig.

Journal: BMC Cancer

Article Title: Distinct roles for the RNA-binding protein Staufen1 in prostate cancer

doi: 10.1186/s12885-021-07844-2

Figure Lengend Snippet: Staufen1 knockdown inhibits Prostate Cancer cell invasion and motility. Motility and Invasion assays were performed following 48 h of Control (CTL) or Staufen1-shRNA (shStau1) expression. a Western blot analysis of Staufen1 expression showing a representative blot of Staufen1 with β-actin as a loading control in PC3 and DU145 cells. Each representative blot is cropped to show an n = 1 for each cell line from their respective full-length blot. Note that the DU145 cells used for Fig. 4 were also used for Fig. experiments and therefore a different representative image from the same blot was selected for each figure. Quantification of n = 4 is represented normalized to CTL. Data are Mean ± SD, One-Sample T-Test, **P < 0.01, ***P < 0.001. b Cells were seeded into transwell chambers containing membranes coated with or without Matrigel and incubated for 72 h and 24 h for PC3 and DU145 cells, respectively. Representative images of cells that passed through the transwell chamber at 40X magnification, scale bar = 20 μm, are displayed. Average number of cells/field of view is quantified for cell motility (no matrigel) and invasion (matrigel) as a percentage relative to CTL. Quantifications are for all data are n = 4. Data are Mean ± SD, Students T-Test, **P < 0.01, ***P < 0.001. Full length blots are presented in Supplemental Fig.

Article Snippet: Infected cells (2.5 × 10 4 ) were seeded in serum free medium in Corning ® BioCoatTM Control Inserts (#354578) or Corning ® GFR Matrigel ® Basement Membrane Matrix Invasion Chambers (#354480) (VWR International, Ontario, Canada) containing growth medium in the bottom chamber.

Techniques: Knockdown, Control, shRNA, Expressing, Western Blot, Incubation

Immunofluorescent staining for (a) CD31 (green) and (b) VE-Cadherin (red) in human iPS cell-derived endothelial cells. Nuclei were visualized with DAPI (blue). (c-g) Relative mRNA log 0 ratio in endothelial cells at differentiation day 9 (EC (D9)) and undifferentiated human iPS cell (iPSC) compared with human umbilical vein endothelial cell (HUVEC). CD31 (c), VE-Cadherin (d), eNOS (e), CD34 (f), and CD133 (g). (h) Tube formation assay. Human iPS cell-derived endothelial cells were recultured on Matrigel Basement Membrane Matrix GFR coated dish. (i) Immunofluorescent stained of CD31 for recultured cells on Matrigel. (j,k) Acetyl-LDL incorporation assay. Endothelial cells were incubated with acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL). Bright-field (j) and fluorescent (k) images. Scale bars: 50 μm in (a), (b) and (i), 100 μm in (h), 200 μm in (j) and (k).

Journal: PLoS ONE

Article Title: Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP

doi: 10.1371/journal.pone.0173271

Figure Lengend Snippet: Immunofluorescent staining for (a) CD31 (green) and (b) VE-Cadherin (red) in human iPS cell-derived endothelial cells. Nuclei were visualized with DAPI (blue). (c-g) Relative mRNA log 0 ratio in endothelial cells at differentiation day 9 (EC (D9)) and undifferentiated human iPS cell (iPSC) compared with human umbilical vein endothelial cell (HUVEC). CD31 (c), VE-Cadherin (d), eNOS (e), CD34 (f), and CD133 (g). (h) Tube formation assay. Human iPS cell-derived endothelial cells were recultured on Matrigel Basement Membrane Matrix GFR coated dish. (i) Immunofluorescent stained of CD31 for recultured cells on Matrigel. (j,k) Acetyl-LDL incorporation assay. Endothelial cells were incubated with acetylated LDL labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL). Bright-field (j) and fluorescent (k) images. Scale bars: 50 μm in (a), (b) and (i), 100 μm in (h), 200 μm in (j) and (k).

Article Snippet: Briefly, differentiated ECs (7 x 10 4 ) at d13 were plated on a 24-well plate (Thermo Fisher Scientific) coated with 300 μl Matrigel Basement Membrane Matrix GFR (BD Biosciences), and cultured for 24 hrs.

Techniques: Staining, Derivative Assay, Tube Formation Assay, Incubation, Labeling